Research programme: autoimmune disease therapeutics - Scipher Therapeutics
Latest Information Update: 13 May 2021
At a glance
- Originator Scipher Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Autoimmune disorders